BlackRock Institutional Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BFA
BG
BlackRock Institutional Trust's PFE Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Pfizer (PFE) stake by 2% in Q4 2016, buying an estimated $105M and bringing the position to 176,536,054 shares worth $5.44B. The position accounts for 0.81% of the portfolio, ranked #18.
BlackRock Institutional Trust first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.99B in Q1 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.
- BlackRock Institutional Trust held 176,536,054 shares of Pfizer worth $5.44B as of Q4 2016.
- BlackRock Institutional Trust bought 3,447,878 Pfizer shares in Q4 2016, an estimated $105M.
- Pfizer made up 0.81% of BlackRock Institutional Trust's portfolio in Q4 2016, its #18 holding.
- BlackRock Institutional Trust first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Pfizer position peaked at $5.99B in Q1 2015.
- 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.